NeoGenomics, Inc. (NEO): Price and Financial Metrics

NeoGenomics, Inc. (NEO)

Today's Latest Price: $39.62 USD

1.63 (-3.95%)

Updated Oct 28 10:52am

Add NEO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

NEO Stock Summary

  • NEO's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 292.53 -- higher than 88.19% of US-listed equities with positive expected earnings growth.
  • Price to trailing twelve month operating cash flow for NEO is currently 273.44, higher than 98.7% of US stocks with positive operating cash flow.
  • Over the past twelve months, NEO has reported earnings growth of -295.29%, putting it ahead of only 6.42% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Neogenomics Inc are TREE, HURC, GHSI, CVV, and LOPE.
  • Visit NEO's SEC page to see the company's official filings. To visit the company's web site, go to

NEO Stock Price Chart Interactive Chart >

Price chart for NEO

NEO Price/Volume Stats

Current price $39.62 52-week high $44.58
Prev. close $41.25 52-week low $20.47
Day low $38.89 Volume 143,871
Day high $40.50 Avg. volume 900,950
50-day MA $38.46 Dividend yield N/A
200-day MA $32.63 Market Cap 4.38B

NeoGenomics, Inc. (NEO) Company Bio

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company was founded in 2001 and is based in Fort Myers, Florida.

NEO Latest News Stream

Event/Time News Detail
Loading, please wait...

NEO Latest Social Stream

Loading social stream, please wait...

View Full NEO Social Stream

Latest NEO News From Around the Web

Below are the latest news stories about Neogenomics Inc that investors may wish to consider to help them evaluate NEO as an investment opportunity.

NeoGenomics (NEO) Investor Presentation - Slideshow

The following slide deck was published by NeoGenomics, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 2, 2020

NeoGenomics, Inc. (NASDAQ:NEO) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates

It's been a good week for NeoGenomics, Inc. (NASDAQ:NEO) shareholders, because the company has just released its...

Yahoo | July 30, 2020

NeoGenomics EPS beats by $0.06, beats on revenue

NeoGenomics (NEO): Q2 Non-GAAP EPS of -$0.04 beats by $0.06; GAAP EPS of -$0.06 beats by $0.08.Revenue of $87M (-14.5% Y/Y) beats by $0.45M.Gross margin for Clinical revenue of 34.0%.Press Release...

Seeking Alpha | July 28, 2020

Earnings Preview: NeoGenomics (NEO) Q2 Earnings Expected to Decline

NeoGenomics (NEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 21, 2020

NeoGenomics Announces Board Appointments

FT MYERS, FL / ACCESSWIRE / July 20, 2020 / NeoGenomics, Inc.

Yahoo | July 20, 2020

Read More 'NEO' Stories Here

NEO Price Returns

1-mo 9.57%
3-mo 3.34%
6-mo 52.38%
1-year 69.61%
3-year 366.67%
5-year 461.99%
YTD 35.45%
2019 131.96%
2018 42.33%
2017 3.38%
2016 8.89%
2015 88.73%

Continue Researching NEO

Here are a few links from around the web to help you further your research on Neogenomics Inc's stock as an investment opportunity:

Neogenomics Inc (NEO) Stock Price | Nasdaq
Neogenomics Inc (NEO) Stock Quote, History and News - Yahoo Finance
Neogenomics Inc (NEO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7314 seconds.